CSF3 and acute myeloid leukemia: To establish clinical relevance for our findings we evaluated the activity of RALB-TBK1 signaling in primary patient-derived AML blasts, and found that primary leukemic blasts had higher levels of phosphorylated TBK1 compared to normal blood leukocytes from G-CSF mobilized peripheral blood donors (Figure 5).